Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study

John S. Welch; Jeffery M. Klco; Feng Gao; Elizabeth Procknow; Geoffery L. Uy; Keith E. Stockerl-Goldstein; Camille N. Abboud; Peter Westervelt; John F. DiPersio; Anjum Hassan; Amanda F. Cashen; Ravi Vij

doi:10.1002/ajh.22092

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study

John S. Welch, Jeffery M. Klco, Feng Gao, Elizabeth Procknow, Geoffery L. Uy, Keith E. Stockerl-Goldstein, Camille N. Abboud, Peter Westervelt, John F. DiPersio, Anjum Hassan, Amanda F. Cashen, Ravi Vij

Research output: Contribution to journal › Letter › peer-review

36 Scopus citations

Original language	English
Pages (from-to)	796-800
Number of pages	5
Journal	American journal of hematology
Volume	86
Issue number	9
DOIs	https://doi.org/10.1002/ajh.22092
State	Published - Sep 2011

Access to Document

10.1002/ajh.22092

Cite this

Welch, J. S., Klco, J. M., Gao, F., Procknow, E., Uy, G. L., Stockerl-Goldstein, K. E., Abboud, C. N., Westervelt, P., DiPersio, J. F., Hassan, A., Cashen, A. F., & Vij, R. (2011). Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study. American journal of hematology, 86(9), 796-800. https://doi.org/10.1002/ajh.22092

Welch, John S. ; Klco, Jeffery M. ; Gao, Feng ; Procknow, Elizabeth ; Uy, Geoffery L. ; Stockerl-Goldstein, Keith E. ; Abboud, Camille N. ; Westervelt, Peter ; DiPersio, John F. ; Hassan, Anjum ; Cashen, Amanda F. ; Vij, Ravi. / Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia : A phase I study. In: American journal of hematology. 2011 ; Vol. 86, No. 9. pp. 796-800.

@article{eb2641716efc4c47a9132eb133a6df33,

title = "Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study",

author = "Welch, {John S.} and Klco, {Jeffery M.} and Feng Gao and Elizabeth Procknow and Uy, {Geoffery L.} and Stockerl-Goldstein, {Keith E.} and Abboud, {Camille N.} and Peter Westervelt and DiPersio, {John F.} and Anjum Hassan and Cashen, {Amanda F.} and Ravi Vij",

year = "2011",

month = sep,

doi = "10.1002/ajh.22092",

language = "English",

volume = "86",

pages = "796--800",

journal = "American Journal of Hematology",

issn = "0361-8609",

number = "9",

}

Welch, JS, Klco, JM, Gao, F, Procknow, E, Uy, GL , Stockerl-Goldstein, KE , Abboud, CN , Westervelt, P , DiPersio, JF , Hassan, A , Cashen, AF & Vij, R 2011, 'Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study', American journal of hematology, vol. 86, no. 9, pp. 796-800. https://doi.org/10.1002/ajh.22092

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia : A phase I study. / Welch, John S.; Klco, Jeffery M.; Gao, Feng; Procknow, Elizabeth; Uy, Geoffery L.; Stockerl-Goldstein, Keith E.; Abboud, Camille N.; Westervelt, Peter ; DiPersio, John F.; Hassan, Anjum ; Cashen, Amanda F.; Vij, Ravi.

In: American journal of hematology, Vol. 86, No. 9, 09.2011, p. 796-800.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia

T2 - A phase I study

AU - Welch, John S.

AU - Klco, Jeffery M.

AU - Gao, Feng

AU - Procknow, Elizabeth

AU - Uy, Geoffery L.

AU - Stockerl-Goldstein, Keith E.

AU - Abboud, Camille N.

AU - Westervelt, Peter

AU - DiPersio, John F.

AU - Hassan, Anjum

AU - Cashen, Amanda F.

AU - Vij, Ravi

PY - 2011/9

Y1 - 2011/9

UR - http://www.scopus.com/inward/record.url?scp=80051801919&partnerID=8YFLogxK

U2 - 10.1002/ajh.22092

DO - 10.1002/ajh.22092

M3 - Letter

C2 - 21815182

AN - SCOPUS:80051801919

VL - 86

SP - 796

EP - 800

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 9

ER -

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study

Access to Document

Other files and links

Cite this